nodes	percent_of_prediction	percent_of_DWPC	metapath
Forasartan—AGTR1—Arf6 trafficking events—VAMP3—Crohn's disease	0.195	0.197	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—LRRK2—Crohn's disease	0.0425	0.0429	CbGpPWpGaD
Forasartan—AGTR1—Peptide GPCRs—CCR9—Crohn's disease	0.0409	0.0413	CbGpPWpGaD
Forasartan—AGTR1—Arf6 trafficking events—ITGA4—Crohn's disease	0.03	0.0302	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0293	0.0296	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—MLN—Crohn's disease	0.0281	0.0284	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.0278	0.028	CbGpPWpGaD
Forasartan—AGTR1—Peptide GPCRs—CCR6—Crohn's disease	0.0271	0.0274	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.0252	0.0254	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0229	0.0231	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IL17A—Crohn's disease	0.0223	0.0225	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IL12B—Crohn's disease	0.0207	0.0209	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0196	0.0198	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.0192	0.0194	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0186	0.0188	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—GPR65—Crohn's disease	0.0181	0.0183	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.0162	0.0164	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IL10—Crohn's disease	0.0152	0.0153	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.0151	0.0152	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—ACKR2—Crohn's disease	0.015	0.0151	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—MLN—Crohn's disease	0.0142	0.0143	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.014	0.0141	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IL2RA—Crohn's disease	0.0135	0.0136	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0129	0.013	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.0127	0.0129	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.012	0.0121	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00998	0.0101	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CCR9—Crohn's disease	0.00983	0.00992	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00937	0.00945	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GPR65—Crohn's disease	0.00914	0.00922	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IFNG—Crohn's disease	0.00892	0.009	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00879	0.00887	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00855	0.00863	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00838	0.00845	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Crohn's disease	0.00832	0.0084	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—CXCL8—Crohn's disease	0.00829	0.00837	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—MLN—Crohn's disease	0.00802	0.00809	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IL1B—Crohn's disease	0.00795	0.00803	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—ACKR2—Crohn's disease	0.00768	0.00775	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00753	0.0076	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—MLN—Crohn's disease	0.00728	0.00734	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CCR6—Crohn's disease	0.00651	0.00657	CbGpPWpGaD
Forasartan—Valsartan—ALB—Crohn's disease	0.00605	0.672	CrCbGaD
Forasartan—AGTR1—Allograft Rejection—TNF—Crohn's disease	0.00577	0.00582	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—PTGER4—Crohn's disease	0.00573	0.00579	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CCR9—Crohn's disease	0.00556	0.00561	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GPR65—Crohn's disease	0.00516	0.00521	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCR9—Crohn's disease	0.00505	0.00509	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GPR65—Crohn's disease	0.00469	0.00473	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ACKR2—Crohn's disease	0.00454	0.00458	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MLN—Crohn's disease	0.0043	0.00434	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00427	0.00431	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00411	0.00415	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00408	0.00411	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TAGAP—Crohn's disease	0.00393	0.00397	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CCR6—Crohn's disease	0.00368	0.00371	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RSPO3—Crohn's disease	0.00344	0.00347	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCR6—Crohn's disease	0.00334	0.00337	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SEL1L—Crohn's disease	0.00326	0.00329	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00324	0.00327	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCR9—Crohn's disease	0.00298	0.00301	CbGpPWpGaD
Forasartan—Losartan—ALB—Crohn's disease	0.00296	0.328	CrCbGaD
Forasartan—AGTR1—Signaling by GPCR—PTGER4—Crohn's disease	0.00294	0.00297	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GPR65—Crohn's disease	0.00277	0.0028	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—IL3—Crohn's disease	0.00276	0.00278	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00276	0.00278	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00267	0.00269	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL3—Crohn's disease	0.00251	0.00253	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00242	0.00245	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CXCL8—Crohn's disease	0.0021	0.00212	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00209	0.00211	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCR6—Crohn's disease	0.00197	0.00199	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—IL2RA—Crohn's disease	0.00193	0.00195	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RBX1—Crohn's disease	0.00179	0.0018	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL2RA—Crohn's disease	0.00176	0.00177	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PTGER4—Crohn's disease	0.00174	0.00175	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—UBE2D1—Crohn's disease	0.00157	0.00158	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RIPK2—Crohn's disease	0.00152	0.00153	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL3—Crohn's disease	0.00148	0.00149	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RASGRP1—Crohn's disease	0.00143	0.00144	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—JAK2—Crohn's disease	0.0013	0.00131	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SOCS1—Crohn's disease	0.0013	0.00131	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—TYK2—Crohn's disease	0.00124	0.00125	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CXCL8—Crohn's disease	0.00119	0.0012	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—JAK2—Crohn's disease	0.00118	0.00119	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SMAD3—Crohn's disease	0.00112	0.00113	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CXCL8—Crohn's disease	0.00108	0.00109	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL2RA—Crohn's disease	0.00104	0.00105	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TYK2—Crohn's disease	0.000731	0.000737	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—JAK2—Crohn's disease	0.000697	0.000703	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CXCL8—Crohn's disease	0.000636	0.000642	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL6—Crohn's disease	0.000605	0.00061	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—STAT3—Crohn's disease	0.000512	0.000516	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL6—Crohn's disease	0.000357	0.000361	CbGpPWpGaD
